Overview

Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin

Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
0
Participant gender:
All
Summary
This is a study to understand efficacy and safety of investigational agent (PF-04937319) compared to approved agent (glimepiride) in patients with diabetes on metformin
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Pfizer
Treatments:
Glimepiride
Metformin
Criteria
Inclusion Criteria:

- Age 18-70 yrs, male and females, with T2DM, on metformin alone or in combination with
1 other oral agent

Exclusion Criteria:

- Subjects with recent cardiovascular events, those with evidence of diabetic
complications